Publications from the Cincinnati Center for Eosinophilic Disorders
Hwee J, Huynh L, Pongdee T, Rothenberg ME, Alfonso-Cristancho R, da Costa Junior W, Duh MS. High disease burden and oral corticosteroid use in patients with hypereosinophilic syndrome and eosinophilic granulomatosis with polyangiitis: country-level insights into real-world management in Europe. J Clin Med. 2025 Jun 17;14(12):4309. doi: 10.3390/jcm14124309. PMID: 40566054; PMCID: PMC12194356.
Hwee J, Huynh L, da Costa W Jr, Rothenberg ME, Duh MS, Alfonso-Cristancho R. Steroid-sparing benefits of biologic use in hypereosinophilic syndrome and substantial disease burden across subtypes. Front Allergy. 2025 May 23;6:1605397. doi: 10.3389/falgy.2025.1605397. PMID: 40486501; PMCID: PMC12143263.
Collins MH, Rothenberg ME, Dellon ES, Bredenoord AJ, Hirano I, Leung J, Sun X, Glotfelty L, Shabbir A. Dupilumab improves histopathologic features in patients with eosinophilic esophagitis: LIBERTY EoE TREET study results. Gastro Hep Adv. 2025 Feb 24;4(6):100646. doi: 10.1016/j.gastha.2025.100646. PMID: 40487268; PMCID: PMC12143628.
Melo RCN, Rothenberg ME. Imaging eosinophil secretory granules: From storage containers to active, immune responder organelles. J Allergy Clin Immunol. 2025 Feb;155(2):414-417. doi: 10.1016/j.jaci.2024.12.1069. PMID: 39709031.
Mehta P, Pan Z, Furuta GT, Kliewer K; Consortium of Eosinophilic Gastrointestinal Disease Researchers. Empiric elimination diets for eosinophilic esophagitis: Barriers, facilitators, and impact on quality of life. J Allergy Clin Immunol Pract. 2025 Feb;13(2):434-436. doi: 10.1016/j.jaip.2024.10.030. PMID: 39489217; PMCID: PMC11807737.
